The FDA has cleared a second carcass-feasting fly species, Lucilia cuprina, for maggot wound therapy. Cuprina Holdings now holds FDA clearance for two species, aiming to dominate the global maggot market.
UniQure plans to seek FDA accelerated approval for its Huntington's disease gene therapy, using three-year data from a Phase 1/2 study. This follows a recent FDA meeting that reversed previous criticisms of the evidence, with shares soaring 70%.
A gene therapy for Huntington's disease, AMT-130, has a renewed path to FDA approval after the departure of Vinay Prasad, who had previously blocked the therapy's accelerated approval process. The FDA has once again agreed that UniQure can pursue approval with trial data using standard care patients as controls, avoiding sham surgeries.
Streamer Lacari returned to Twitch after a hiatus, addressing past controversies and allegations. He stated an independent forensic review found no illegal content on his devices and discussed his personal struggles with stress, anxiety, and addiction, highlighting his therapy and recovery efforts.
An NHS trust has been fined £300,000 after admitting to failing to provide safe care to Chris Elliot, 59, who died from a pseudomonas aeruginosa infection contracted from a contaminated hospital shower while undergoing chemotherapy for leukaemia at Cheltenham General Hospital.
Poolbeg Pharma will trial its oral drug POLB 001 at six NHS hospitals to prevent cytokine release syndrome (CRS), a dangerous side-effect of cancer immunotherapy. The drug could improve patient safety and save healthcare systems millions by allowing treatment outside specialist centers.
Rusty, a 3-year-old Falabella miniature horse, travels by taxi in London to provide therapy for his owner, Maria Johal, who suffers from PTSD and panic attacks. As a registered therapy animal, Rusty helps Maria feel less isolated and more connected to her community. Maria also cares for Tayto, a 10-month-old rescue horse, who is learning from Rusty.
Russia has seen a 48% decrease in its HIV incidence rate since 2016, with coverage of antiretroviral therapy reaching 91.8% in 2025. New HIV cases have also fallen by over half.
Five NHS patients in England with severe lupus are in remission after receiving CAR T-cell therapy, a groundbreaking treatment that genetically modifies immune cells to reset the immune system, offering hope for a potential cure.
Taiwan's Insurance Bureau has excluded home cancer chemotherapy from new in-home acute care insurance due to a lack of statistical data on its incidence. Current policies only cover pneumonia, urinary tract infections, and soft tissue infections. Insurers will use data from these three conditions to develop future policies for home cancer treatment.
衛福部新營醫院導入「AI懷舊治療」，利用AI影像修復與動態生成技術，將長者老照片轉化為生動動態影像，有效刺激失智症患者喚醒記憶，找回與親人的連結，提升生活尊嚴。
A Bengaluru consumer commission dismissed a woman's negligence claim against Dr. Jamuna Pai's SkinLab, ruling that expert medical evidence is required to prove negligence in cosmetic treatments. The complainant alleged worsened acne and hair growth after Glutathione IV therapy and LHR, but failed to provide expert medical opinions to support her claims.
Taiwan's Health Minister Shiu-Chung Liang is urging insurance companies to update policies to cover home-based cancer chemotherapy. Many existing policies require hospitalization for claims, hindering the adoption of more cost-effective and patient-friendly home care models, which can halve medical costs.
Taiwan's Ministry of Health and Welfare (MOHW) plans to discuss with the Financial Supervisory Commission and insurers to adjust cancer insurance policies. The goal is to enable coverage for home-based chemotherapy and other new care models, as current policies often require hospitalization, leading to unnecessary bed occupancy.
Taiwan's Ministry of Health and Welfare and the Financial Supervisory Commission are working to enable home-based chemotherapy for cancer patients, addressing insurance coverage issues to allow treatment outside hospitals by the second half of the year.
Two former medical school classmates, Manuel and Alejandro Martín, reunited as patient and doctor when Manuel became the first CAR-T therapy patient in Salamanca. Manuel, treated for lymphoma, is now a long-term survivor, highlighting the therapy's evolution.
Thousands of men in England diagnosed with low- or intermediate-risk prostate cancer will be offered SABR, a precision radiotherapy that reduces treatment sessions from 20 to five. This advanced technique targets the disease more effectively, minimizing side effects and allowing patients to return to normal life sooner. NHS England expects all 48 radiotherapy centers to offer the treatment within weeks.
Richard Scolyer, 59, renowned Australian cancer specialist and co-medical director at Melanoma Institute Australia, dies after pioneering an experimental brain tumour treatment, leaving a legacy in melanoma care through his work with immunotherapy.
Prof Richard Scolyer, a celebrated cancer researcher and 2024 Australian of the Year, has died at 59 after a public battle with inoperable brain cancer, leaving a legacy of inspiration and groundbreaking medical contributions.
Doomspending, a new term for frivolous spending driven by economic anxiety, reflects a generational shift in financial outlook among young Westerners. Unlike previous generations who prioritized saving, Gen Z and millennials are spending now due to perceived declining economic fortunes and a loss of faith in traditional financial systems.
South Korea will cap manual therapy costs at approximately 40,000 won per session and limit it to 15 sessions per year starting next month. A pilot program will also be launched for telemedicine in rural areas facing reduced medical access due to a shortage of public health doctors.
Researchers at Texas A&M University have developed a new nasal spray therapy using extracellular vesicles (EVs) derived from human neural stem cells. This therapy effectively reduces chronic brain inflammation in aged mice, restoring memory and cognitive functions by blocking inflammatory signaling pathways and shifting brain immune cells to a protective mode.
As high school and middle school exams approach, some students are seeking hyperbaric oxygen therapy, believing it can boost brain function. Doctors warn it's not a 'brain-charging' tool and carries risks, urging reliance on sleep, diet, and stress management instead.
NHS England has approved mirvetuximab soravtansine (Elahere) for women with platinum-resistant ovarian cancer, marking the first new drug for this condition in over 20 years. The treatment, administered every three weeks, delayed cancer progression and prolonged survival by an average of four months in clinical trials.
